News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
Formulation Development: Fastest-to-FIH Without Sacrificing Quality
For biotechs and innovators, we all agree that speed to clinic is paramount. What if your work in CMC, within the same timeline and budget, could result in a market-quality drug product for Phase I?
In this discussion, CMC experts across the industry will outline a 3-step process to achieve “speed to and through the clinic.” Our panel will apply this approach to real redacted projects. We will demonstrate how you can gain visibility to future clinical trials while detailing potential inefficiencies and best practices.
4:45-5 pm - Checkin & Refreshments
5-6 pm – Panel
6-9 pm – BiotechTuesday
Location: La Fabrica Central, 450 Massachusetts Ave, Cambridge, MA 02139
Date and Time: Tue, Apr 2, 2024 5:00 PM - 6:00 PM
Register for the discussion: https://lnkd.in/e677WQtt
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
